These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18458643)

  • 61. [Monoclonal antibodies in nephrology: a delicate balance between curative potential, evidence of effectiveness, and toxicity].
    Magistroni R
    G Ital Nefrol; 2012; 29(3):283-91; discussion 292. PubMed ID: 22718451
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.
    Terrier B; Krastinova E; Marie I; Launay D; Lacraz A; Belenotti P; de Saint-Martin L; Quemeneur T; Huart A; Bonnet F; Le Guenno G; Kahn JE; Hinschberger O; Rullier P; Diot E; Lazaro E; Bridoux F; Zénone T; Carrat F; Hermine O; Léger JM; Mariette X; Senet P; Plaisier E; Cacoub P
    Blood; 2012 Jun; 119(25):5996-6004. PubMed ID: 22474249
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches.
    Fabrizi F; Lunghi G; Messa P; Martin P
    J Nephrol; 2008; 21(6):813-25. PubMed ID: 19034865
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rituximab and pemphigus--a therapeutic advance.
    Diaz LA
    N Engl J Med; 2007 Aug; 357(6):605-7. PubMed ID: 17687137
    [No Abstract]   [Full Text] [Related]  

  • 65. Rituximab: an update.
    Hughes G
    Lupus; 2007; 16(7):529-30. PubMed ID: 17670854
    [No Abstract]   [Full Text] [Related]  

  • 66. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.
    Ferri C; Cacoub P; Mazzaro C; Roccatello D; Scaini P; Sebastiani M; Tavoni A; Zignego AL; De Vita S
    Autoimmun Rev; 2011 Nov; 11(1):48-55. PubMed ID: 21821153
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monoclonal antibodies for podocytopathies: rationale and clinical responses.
    Marasà M; Kopp JB
    Nat Rev Nephrol; 2009 Jun; 5(6):337-48. PubMed ID: 19474828
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Good response to treatment with rituximab in a child with refractory idiopathic thrombocytopenic purpura].
    Fríguls-Francitorra B; Almazán-Castro F; Manchón GJ
    Med Clin (Barc); 2006 Sep; 127(12):478-9. PubMed ID: 17040639
    [No Abstract]   [Full Text] [Related]  

  • 69. Role of rituximab therapy in glomerulonephritis.
    Jayne D
    J Am Soc Nephrol; 2010 Jan; 21(1):14-7. PubMed ID: 18799717
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome.
    Carey EJ; Somaratne K; Rakela J
    Rev Med Chil; 2011 Nov; 139(11):1484-7. PubMed ID: 22446656
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Giant cell hepatitis and immune thrombocytopenic purpura: reversal of liver failure with rituximab therapy.
    Shores D; Kobak G; Pegram LD; Whitington PF; Shneider BL
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):e128-30. PubMed ID: 21921813
    [No Abstract]   [Full Text] [Related]  

  • 72. Response to rituximab in patients with type II cryoglobulinemia.
    Bryce AH; Dispenzieri A; Kyle RA; Lacy MQ; Rajkumar SV; Inwards DJ; Yasenchak CA; Kumar SK; Gertz MA
    Clin Lymphoma Myeloma; 2006 Sep; 7(2):140-4. PubMed ID: 17026826
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Successful treatment of pemphigus foliaceus with rituximab. Report of 3 cases].
    Alter M; Wittmann M; Völker B; Kapp A; Werfel T; Gutzmer R
    Hautarzt; 2009 Sep; 60(9):743-8. PubMed ID: 19151961
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glomerulonephritis in mixed cryoglobulinaemia: what treatment?
    Campise M; Tarantino A
    Nephrol Dial Transplant; 1999 Feb; 14(2):281-3. PubMed ID: 10069172
    [No Abstract]   [Full Text] [Related]  

  • 75. [Treatment of severe refractory pemphigus vulgaris with rituximab].
    Pitarch G; Sánchez-Carazo JL; Pardo J; Torrijos A; Roche E; Fortea JM
    Actas Dermosifiliogr; 2006; 97(1):48-51. PubMed ID: 16540052
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
    Aleem A
    Ann Saudi Med; 2008; 28(5):382-5. PubMed ID: 18779631
    [No Abstract]   [Full Text] [Related]  

  • 77. [Treatment of systemic autoimmune and inflammatory diseases with rituximab].
    Bussone G; Hachulla E; Sibilia J; Michel M; Godeau B; Guillevin L; Mouthon L
    Presse Med; 2009 May; 38(5):808-23. PubMed ID: 19297127
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of rituximab in the antiphospholipid syndrome.
    Kumar D; Roubey RA
    Curr Rheumatol Rep; 2010 Feb; 12(1):40-4. PubMed ID: 20425532
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection.
    Mak SK; Lo KY; Lo MW; Chan SF; Lo KC; Wong YY; Tong GM; Wong PN; Ma ES; Wong AK
    Hong Kong Med J; 2009 Jun; 15(3):201-8. PubMed ID: 19494376
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of type II cryoglobulinemia associated with hepatitis C with rituximab.
    Pekow J; Chung RT
    J Clin Gastroenterol; 2006; 40(5):450. PubMed ID: 16721231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.